Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavan Reddy

Showing results (191-200 of 228) with videos related to

Pageof 23
Sort By:
Nature Medicine|October 19, 2023
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantationMary M Riwes, Jonathan L Golob, John Magenau, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
Blood|August 30, 2023
A phase 2 trial of CD24Fc for prevention of graft-versus-host diseaseJohn Magenau, Samantha Jaglowski, Joseph Uberti, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Science Translational Medicine|March 18, 2021
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies <i>Linc00402</i> as a regulator of T cell alloimmunityDaniel Peltier, Molly Radosevich, Visweswaran Ravikumar, et al.
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Circulation. Cardiovascular Interventions|June 10, 2024
Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art ReviewKalyan R Chitturi, Amer I Aladin, Ryan Braun, et al.
Pageof 23

Showing results (191-200 of 228) with videos related to

Sort By:
Pageof 23
Nature Medicine|October 19, 2023
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantationMary M Riwes, Jonathan L Golob, John Magenau, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
Blood|August 30, 2023
A phase 2 trial of CD24Fc for prevention of graft-versus-host diseaseJohn Magenau, Samantha Jaglowski, Joseph Uberti, et al.
Blood|October 4, 2008
A biomarker panel for acute graft-versus-host diseaseSophie Paczesny, Oleg I Krijanovski, Thomas M Braun, et al.
Science Translational Medicine|March 18, 2021
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies <i>Linc00402</i> as a regulator of T cell alloimmunityDaniel Peltier, Molly Radosevich, Visweswaran Ravikumar, et al.
The New England Journal of Medicine|August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and deathMark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Circulation. Cardiovascular Interventions|June 10, 2024
Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art ReviewKalyan R Chitturi, Amer I Aladin, Ryan Braun, et al.
Pageof 23